NCT01482520 Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01481805 Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients Status COMPLETED Phase N/A
NCT01480817 Sorafenib VS TACE in HCC Patients With Portal Vein Invasion Status TERMINATED Phase PHASE2
NCT01466504 Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin Status TERMINATED Phase N/A
NCT01465464 Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma Status TERMINATED Phase PHASE3
NCT01462903 A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors Status UNKNOWN Phase PHASE1
NCT01451658 A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) Status UNKNOWN Phase PHASE4
NCT01447667 Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) Status COMPLETED Phase NA
NCT01441453 Transient Elastography in Hepatectomy for Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT01438450 Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2/PHASE3
NCT01438437 Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis Status UNKNOWN Phase PHASE4
NCT01432314 Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) Status WITHDRAWN Phase PHASE2
NCT01415063 Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT01409499 Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE4
NCT01406574 Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT01402908 A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection Status TERMINATED Phase PHASE3
NCT01392131 Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE1/PHASE2
NCT01387932 HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer Status TERMINATED Phase PHASE3
NCT01387555 A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib Status COMPLETED Phase PHASE2